Please try another search
Milestone triggers payments to PureTech totaling $29 million under agreements with Royalty Pharma and PureTech's Founded Entity, Karuna Therapeutics (NASDAQ:KRTX), which was acquired by Bristol Myers...
COBENFY represents the first new pharmacological approach to treat schizophrenia in decades, with a mechanism of action distinct from current therapiesApproval is supported by data from the EMERGENT...
Aquestive Therapeutics , Inc. (NASDAQ:AQST) is garnering attention from Wall Street as it advances its innovative epinephrine product, Anaphylm. The pharmaceutical company, known for its proprietary...
With the US presidential elections just a few weeks away, we take a look at the economic and social program of the Democratic candidate for the White House. Following the interest rate cut announced...
There is only one way to rescue America’s faltering economy and that’s the wholesale abandonment of Washington’s reckless spending, and borrowing policies of the last quarter century. These policies...
An analysis of Presidential Candidate Trump’s policy proposals recently suggests that tax cuts will increase the deficit. While the raw analysis is correct, as it subtracts the potential for reduced...
Instrument Type
Region
Sector
Industry
Date
Category
Provider